about
Ecto-F1-ATPase and MHC-class I close association on cell membranesPhosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-ILack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport.Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES StudyRNY-derived small RNAs as a signature of coronary artery diseaseRole of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.Identification of the F1-ATPase at the cell surface of colonic epithelial cells: role in mediating cell proliferation.Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humans.PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 Receptors.Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F1-ATPase-mediated HDL endocytosis pathway on hepatocytes.Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase.Serum inhibitory factor 1, high-density lipoprotein and cardiovascular diseases.Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.Association of hepatic lipase -514T allele with coronary artery disease and ankle-brachial index, dependence on the lipoprotein phenotype: the GENES study.Role of the ubiquitin-proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake.Targeting high-density lipoproteins: update on a promising therapy.The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation.A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality.Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway.Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transportDeciphering biased inverse agonism of cangrelor and ticagrelor at P2Y receptorTumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-IChronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretionCommon p2y13 polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass: The GENES studyPharmacological inhibition of the F1 -ATPase/P2Y1 pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxationPaclitaxel induces lymphatic endothelial cells autophagy to promote metastasisLiraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitisSerum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study
P50
Q24321574-31A00E3C-9955-4282-9586-13B5192F2920Q28593742-CE91A6FD-5B9D-42D5-AC62-07979E631FD2Q33642949-26C78D4F-CEFB-4238-9943-E71E6EBA5CA9Q34089207-B81EE5CE-6742-4293-85B7-5E275C1E824DQ34827947-A88A0048-FE63-4AE6-A303-8B6362BA9457Q36110734-D50B7C7C-E8B1-4C77-958D-A3E46D6CB6FEQ36142332-CB40C8B4-684E-479B-B99C-14A15A257E9DQ36388793-5AFD8D2E-9E19-4614-A9AD-1F7E8F41353AQ36436139-83C2087C-123E-4F08-A796-B91E11EA49C0Q37076538-DB817588-1B9E-4D48-BD40-59C028EC96E4Q38273307-9B11F74F-C620-413B-B27F-E447D8CF55ACQ38720609-50686F33-019A-422D-B31C-453B9F7CB02DQ38746424-3787DD78-37FF-486B-A7A1-3B7936A99BB7Q38786323-588BF62F-F3E6-4F91-8902-0D4F9574746DQ39090573-496D1CD8-E7FE-4AF8-8410-3EE8A01A411DQ39306852-BBF02FDB-AB88-4974-97FB-EF02A70DD3F8Q39807695-6C8E82A7-5985-4D13-BF3B-0025C47E9D71Q40208744-B7762608-275D-4AD5-A723-868F53B43AFFQ43099842-0177E4D9-A80B-4B16-BFF6-59F6E5A81D9BQ43560661-9E83F8D3-9FE5-4B3D-A6ED-D1C40A06630CQ45390437-C114DE1B-307A-4C5D-BC5B-11A7C67E7E31Q46757995-687638A0-59DD-413C-B0B8-6CB7C31FA341Q47995788-13BC2807-33C0-486A-9760-0CBEBF96D6FEQ48052752-A9F5E043-00AA-44B7-B8CD-FD2C59AB8151Q51734986-23CA5203-D891-4D21-B304-38C8F5733329Q54389170-F000C823-A108-4D1A-B9DD-FB411EC7BEDBQ57145061-F2CA3F5D-B526-4402-BB4D-92D433E3F03DQ58593716-86090850-191E-4741-8839-2A59BB5E87EDQ81304839-BDE8BF85-C650-47EF-AB68-C45D76588A1EQ85783765-7F982047-56AA-4C2F-853D-E12F7577CD36Q90842602-33F71F75-3D7A-42FE-9FDE-3A54254C3F6FQ92033810-3F263123-2BFF-40BB-815A-5792A35FB30EQ92163838-E87DF91F-08F9-4E9F-A43F-491C7DBA6B75Q92952336-59664CFA-90AE-489D-BD89-9C081B3182C9Q95326868-5C3C92BC-A060-4F13-9CF5-C038D91188A9
P50
description
researcher ORCID ID = 0000-0002-0985-3152
@en
wetenschapper
@nl
name
Laurent O Martinez
@ast
Laurent O Martinez
@en
Laurent O Martinez
@nl
type
label
Laurent O Martinez
@ast
Laurent O Martinez
@en
Laurent O Martinez
@nl
prefLabel
Laurent O Martinez
@ast
Laurent O Martinez
@en
Laurent O Martinez
@nl
P31
P496
0000-0002-0985-3152